drugset / Trial / NCT02865629
N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring
NaSingle-groupOpen-labelTreatment
Summary
N-acetylcysteine in the treatment of depressive symptoms in youth at high-risk for bipolar disorder: a functional connectivity study
Timeline
- Start
- 2016-08
- Primary completion
- 2019-08
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 1200 mg | Oral |